Abstract
To explore the feasibility of using the Non-motor Symptoms Scale (NMSS) to assist in
differentiating drug-induced parkinsonism (DIP) from Parkinson's disease (PD). Methods: A total of 21 patients
with DIP (DIP group), 25 patients with PD who had not received medication treatment (PD group), and 22
patients without Parkinson's symptoms (control group) were selected from May 2023 to May 2024 in the
Department of Neurology of our hospital. Clinical data of the patients were collected, and they were assessed
using the Unified Parkinson's Disease Rating Scale Part III (UPDRS III) and the Hoehn and Yahr Staging Scale
(H-Y). At the same time, the NMSS was used to evaluate the non-motor symptoms. The scale scores and their
correlations among the three groups were compared and analyzed. Results: The scores of the NMSS in the DIP
group and PD group showed significant differences compared with the control group. Except for perception
(delusions of persecution, diplopia), attention and memory (difficulty remembering recent events, forgetting to do
some things), gastrointestinal symptoms (dysphagia), and others (increased sweating), the differences in other
items were statistically significant (P<0.05). Compared with the PD group, the scores of vascular symptoms,
sleep and physical strength (daytime sleepiness, restless legs syndrome), attention and memory (inattentiveness),
gastrointestinal symptoms (ptyalism), urinary symptoms, sexual function, and others (unexplained pain, alteration
of taste and smell sense) in the DIP group were statistically significant (P<0.05). Spearman correlation analysis
showed that the motor symptoms correlation (UPDRS III and H-Y) in the DIP group and PD group was low to
moderately correlated (rs=-0.254, -0.519). Among other items, only sleep and physical strength (daytime sleepiness), attention and memory (inattentiveness), urinary symptoms, and others (alteration of taste and smell senses)
in the DIP group were moderately correlated with those in the PD group (rs=0.370~0.497); sleep and physical
strength (restless legs syndrome) was lowly correlated with the PD group (rs=0.279). No significant correlation
was found in the remaining items (P>0.05). Conclusion: The NMSS score is helpful to improve the accuracy of
differentiating early DIP from PD patients.
Key words
Parkinson's disease
Cite this article
Download Citations
A Feasibility Study on the Use of the Non-motor Symptoms Scale to Differentiate
Drug-induced Parkinsonism[J]. Neural Injury and Functional Reconstruction. 2025, 20(4): 203-206
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}